Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges
- Autores
- Gutman, Graciela Elena; Lavarello, Pablo Jose
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.
Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina
Fil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina - Materia
-
Biotechnology
Pharmaceutics Industry
Firm Strategies
Developing Countries - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/15612
Ver los metadatos del registro completo
id |
CONICETDig_e0e66aeb288cdd40058ebc3214fd321b |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/15612 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challengesGutman, Graciela ElenaLavarello, Pablo JoseBiotechnologyPharmaceutics IndustryFirm StrategiesDeveloping Countrieshttps://purl.org/becyt/ford/5.2https://purl.org/becyt/ford/5In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages.Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; ArgentinaFil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; ArgentinaInderscience Enterprises Ltd2014-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/zipapplication/pdfhttp://hdl.handle.net/11336/15612Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-1781476-5667enginfo:eu-repo/semantics/altIdentifier/url/http://www.inderscienceonline.com/doi/abs/10.1504/IJTG.2014.064740info:eu-repo/semantics/altIdentifier/doi/10.1504/IJTG.2014.064740info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T12:05:52Zoai:ri.conicet.gov.ar:11336/15612instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 12:05:52.764CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
title |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
spellingShingle |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges Gutman, Graciela Elena Biotechnology Pharmaceutics Industry Firm Strategies Developing Countries |
title_short |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
title_full |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
title_fullStr |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
title_full_unstemmed |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
title_sort |
Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges |
dc.creator.none.fl_str_mv |
Gutman, Graciela Elena Lavarello, Pablo Jose |
author |
Gutman, Graciela Elena |
author_facet |
Gutman, Graciela Elena Lavarello, Pablo Jose |
author_role |
author |
author2 |
Lavarello, Pablo Jose |
author2_role |
author |
dc.subject.none.fl_str_mv |
Biotechnology Pharmaceutics Industry Firm Strategies Developing Countries |
topic |
Biotechnology Pharmaceutics Industry Firm Strategies Developing Countries |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/5.2 https://purl.org/becyt/ford/5 |
dc.description.none.fl_txt_mv |
In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages. Fil: Gutman, Graciela Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina Fil: Lavarello, Pablo Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Saavedra 15. Centro de Estudios Urbanos y Regionales; Argentina |
description |
In Argentina, some biotechnology firms operating in the human health sector managed to enter into the biosimilars segment of global biopharmaceutical markets at an early stage. These firms’ forms of organisation and their articulation with local science and technology infrastructure have played a key role in the development of business strategies in an institutional context that does not facilitate the resolution of the particular risks and uncertainties – be they technological, regulatory, or commercial – associated with these products. This paper examines the strategies of selected firms, using case studies. It postulates that firm organisation in economic groups, and the articulation in public/private networks enables local firms to successfully surmount the obstacles faced by innovative biotechnology firms in peripheral countries, which leads in turn to the achievement of technological and financial advantages. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/15612 Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-178 1476-5667 |
url |
http://hdl.handle.net/11336/15612 |
identifier_str_mv |
Gutman, Graciela Elena; Lavarello, Pablo Jose; Biopharmaceuticals and firm organization in Argentina. Opportunities and challenges; Inderscience Enterprises Ltd; International Journal Technology and Globalization; 7; 3; 3-2014; 159-178 1476-5667 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.inderscienceonline.com/doi/abs/10.1504/IJTG.2014.064740 info:eu-repo/semantics/altIdentifier/doi/10.1504/IJTG.2014.064740 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/zip application/pdf |
dc.publisher.none.fl_str_mv |
Inderscience Enterprises Ltd |
publisher.none.fl_str_mv |
Inderscience Enterprises Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846782412299698176 |
score |
13.199325 |